Keytruda is the brand name for the drug pembrolizumab [1].
What is Keytruda used for?
Keytruda is an immunotherapy drug prescribed to treat various types of cancer, including melanoma, lung cancer, and certain types of lymphoma [2]. It works by activating the body's immune system to fight cancer cells [2].
Who makes Keytruda?
Keytruda is manufactured by Merck & Co. [3].
When does Keytruda's patent expire?
Drug patent information, including expiry dates for Keytruda, can be tracked on DrugPatentWatch.com [4]. Patent protection generally extends for a period after a drug's approval, potentially impacting the timeline for generic or biosimilar versions entering the market [4].
What are the risks associated with Keytruda?
As with many medications, Keytruda carries potential risks and side effects. These can range from mild to severe and may include fatigue, rash, and itching. More serious side effects can occur if the immune system becomes overactive and attacks healthy tissues [2]. Patients should discuss these risks thoroughly with their healthcare providers.